Aurinia Pharmaceuticals
AUPH
#4610
Rank
A$3.10 B
Marketcap
A$23.57
Share price
1.50%
Change (1 day)
43.98%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): A$0.12 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.26 Billion. In 2024 the company made an earning of A$18.44 Million, an increase over its 2023 earnings that were of -A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.12 B604.09%
2024 A$18.44 M-116.44%
2023 -A$0.12 Billion-31.8%
2022 -A$0.17 Billion-39.4%
2021 -A$0.28 Billion61.9%
2020 -A$0.17 Billion-9.73%
2019 -A$0.19 Billion92.65%
2018 -A$96.37 Million36.39%
2017 -A$70.66 Million106.29%
2016 -A$34.26 Million-15.4%
2015 -A$40.49 Million65.84%
2014 -A$24.42 Million129.82%
2013 -A$10.63 Million-26.6%
2012 -A$14.48 Million
2010 -A$8.2 Million-39.22%
2009 -A$13.49 Million-43.78%
2008 -A$23.98 Million-53.19%
2007 -A$51.23 Million42.97%
2006 -A$35.84 Million-23.03%
2005 -A$46.56 Million36.1%
2004 -A$34.21 Million172.57%
2003 -A$12.56 Million484.61%
2002 -A$2.15 Million
2000 -A$10.2 Million453.81%
1999 -A$1.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
A$7.72 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$8.24 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-A$33.22 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA